Pathogenesis of paclitaxel-induced peripheral neuropathy: A current review of in vitro and in vivo findings using rodent and human model systems

2019/11/20 by Nathan P. Staff, Jill C. Fehrenbacher, Martial Caillaud +3 · 26 citations
Medicine · #Cancer Treatment and Pharmacology #Multiple Myeloma Research and Treatments #HER2/EGFR in Cancer Research

paper · doi:10.1016/j.expneurol.2019.113121

Cited by

• The Roles of Matrix Metalloproteinases and Their Inhibitors in Human Diseases
• Effects of Electrical Stimulation on Peripheral Nerve Regeneration in a Silicone Rubber Conduit in Taxol-Treated Rats. [europepmc]
• Taxane-induced neurotoxicity: Pathophysiology and therapeutic perspectives. [europepmc]
• Chemotherapy-induced peripheral neuropathy: part 1-current state of knowledge and perspectives for pharmacotherapy. [europepmc]
• Positive Allosteric Modulation of CB 1 Cannabinoid Receptor Signaling Enhances Morphine Antinociception and Attenuates Morphine Tolerance Without Enhancing Morphine- Induced Dependence or Reward. [europepmc]
• A Fenofibrate Diet Prevents Paclitaxel-Induced Peripheral Neuropathy in Mice. [europepmc]
• The Roles of Matrix Metalloproteinases and Their Inhibitors in Human Diseases. [europepmc]
• Targeting T-type/CaV3.2 channels for chronic pain. [europepmc]
• Targeting Peroxisome Proliferator-Activated Receptor-α (PPAR- α) to reduce paclitaxel-induced peripheral neuropathy. [europepmc]
• Paclitaxel increases axonal localization and vesicular trafficking of Nav1.7. [europepmc]
• Current Perspectives on Taxanes: Focus on Their Bioactivity, Delivery and Combination Therapy. [europepmc]
• The Cyr61 Is a Potential Target for Rotundifuran, a Natural Labdane-Type Diterpene from Vitex trifolia L., to Trigger Apoptosis of Cervical Cancer Cells. [europepmc]
• Mechanistic insights into the pathogenesis of microtubule-targeting agent-induced peripheral neuropathy from pharmacogenetic and functional studies. [europepmc]
• Axonal Charcot-Marie-Tooth Disease: from Common Pathogenic Mechanisms to Emerging Treatment Opportunities. [europepmc]
• Capsaicin-induced depolymerization of axonal microtubules mediates analgesia for trigeminal neuropathic pain. [europepmc]
• Biomarkers of Chemotherapy-Induced Peripheral Neuropathy: Current Status and Future Directions. [europepmc]
• Glutamatergic Neurons in the Amygdala Are Involved in Paclitaxel-Induced Pain and Anxiety. [europepmc]
• Paclitaxel binds and activates C5aR1: A new potential therapeutic target for the prevention of chemotherapy-induced peripheral neuropathy and hypersensitivity reactions. [europepmc]
• Analgesic Effect of SH003 and Trichosanthes kirilowii Maximowicz in Paclitaxel-Induced Neuropathic Pain in Mice. [europepmc]
• Paclitaxel Regulates TRPA1 Function and Expression Through PKA and PKC. [europepmc]
• The Preventive Effects of Naringin and Naringenin against Paclitaxel-Induced Nephrotoxicity and Cardiotoxicity in Male Wistar Rats. [europepmc]
• Long-Term Effects of Breast Cancer Therapy and Care: Calm after the Storm? [europepmc]
• Rutin and Hesperidin Alleviate Paclitaxel-Induced Nephrocardiotoxicity in Wistar Rats via Suppressing the Oxidative Stress and Enhancing the Antioxidant Defense Mechanisms. [europepmc]
• Taming microglia: the promise of engineered microglia in treating neurological diseases. [europepmc]
• Spinal HMGB1 participates in the early stages of paclitaxel-induced neuropathic pain via microglial TLR4 and RAGE activation. [europepmc]
• Augustus Waller's foresight realized: SARM1 in peripheral neuropathies. [europepmc]